- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Patrick C. May, Ph.D.
Patrick C. May, Ph.D. is listed as a consultant research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Consultant
In Vitro Assays
- Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
- Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
- Cell Proliferation Measure cell number, cell viability and cell division.
In Vitro Toxicology
- Cytotoxicity Test for effects on cell viability and proliferation
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
Twenty-five plus years of experience in pharmaceutical industry with increasing supervisory and strategic responsibilities. Significant background in most aspects of the drug discovery process in neurologic diseases. Externally recognized expertise ranging from target identification and validation through nonclinical and early phase clinical development. Committed drug hunter with successful track record of delivering multiple high quality clinical candidates. Retired from Eli Lilly in 2014 and now providing independent neuroscience pharmaceutical consulting. Current SAB member and drug...
Show the full description
Twenty-five plus years of experience in pharmaceutical industry with increasing supervisory and strategic responsibilities. Significant background in most aspects of the drug discovery process in neurologic diseases. Externally recognized expertise ranging from target identification and validation through nonclinical and early phase clinical development. Committed drug hunter with successful track record of delivering multiple high quality clinical candidates. Retired from Eli Lilly in 2014 and now providing independent neuroscience pharmaceutical consulting. Current SAB member and drug discovery consultant for the Tau Consortium.
Work with Patrick C. May, Ph.D. on Scientist.com
For prices, more details, or to contact Patrick C. May, Ph.D., visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.